The clinical evaluation of cancer prevention agents

Proceedings of the Society for Experimental Biology and Medicine

Volumn 216, Issue 2, 1997, Pages 253-259

  Goodman, Gary E ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b SWEDISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; RETINOL; RETINOL PALMITATE;

ADULT; ANTINEOPLASTIC ACTIVITY; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; REVIEW; VITAMIN INTAKE;

EID: 0030881274     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-216-44175     Document Type: Review

References (38)

1. Bishop MJ. Molecular themes in oncogenesis. Cell 64:235-248, 1991.
2. Weinstein IB. The origins of human cancer: Molecular mechanisms of carcinogenesis and their implication for cancer prevention and treatment. Cancer Res 48:4135-4143, 1988.
3. Willett WC, MacMahon B. Diet and cancer - An overview (first of two parts). N Engl J Med 310:633-638, 1984.
4. Willett WC, MacMahon B. Diet and cancer - An overview (second of two parts). N Engl J Med 310:697-703, 1984.
5. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer prevention: A review. J Am Diet Assoc 96:1027-1039, 1996.
6. Dragsted JO, Strube M, Larsen JC. Cancer-protective factors in fruits and vegatables: Biochemical and biological background. Pharmacol Toxic 72(Suppl 1):116-135, 1993.
7. Bertram JS, Kolonel LN, Meyskens FL Jr. Rationale and strategies for chemoprevention of cancer in humans. Cancer Res 47:3012-3031, 1987.
8. Boone CW, Kelloff GJ, Malne WE. Identification of candidate cancer chemoprevention agents and their evaluation in animal models and human clinical trials: A review. Cancer Res 50:2-9, 1990.
9. Greenwald P. New directions of chemoprevention research. In: Pastorino U, Hong WK, Eds. Proceedings of the 1st International Conference on Chemo-immuno Prevention of Cancer; Aug 24-25, Vienna, Austria. New York: Thiemes Medical Publishers, pp1-7, 1991.
10. Goodman GE. The clinical evaluation of cancer chemoprevention agents: Defining and contrasting phase I, II and III objectives. Cancer Res (Suppl) 52:2752S-2757S, 1992.
11. Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet R, Sigman CC. Chemopreventive drug development: perspectives and progress. Cancer Epidemiol Biomarkers Prev 3:85-98, 1994.
12. Prentice RL. Surrogate endpoints in clinical trials: Definition and operational criteria. Stat Med 8:431-440, 1989.
13. Shin DM, Hittelman WN, Hong WK. Biomarkers in upper aerodigestive tract tumorigenesis: A review. Cancer Epidemiol Biomarkers Prev 3:697-709, 1994.
14. Fiala ES, Reddy BS, Weisburger JH. Naturally occurring anticarcinogenic substances in foodstuffs. Annu Rev Nutr 5:295-321, 1985.
15. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150-1155, 1996.
16. Gerster H. Anticarcinogenic effect of common carotenoids. Int J Vitam Nutr Res 63:93-121, 1993.
17. Toma S, Losardo PL, Vincent M, Palumbo R. Effectiveness of β-carotene in cancer chemoprevention. Eur J Cancer Prev 4:213-224, 1995.
18. Sies H, Stahl W, Sundquist AR. Antioxidant functions of vitamins. Ann NY Acad Sci 699:7-20, 1992.
19. Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce human cancer rates? Nature 290:201-209, 1981.
20. Kark JD, Smith AH, Switzer BR, Hames CG. Serum vitamin A (retinol) and cancer incidence in Evans County, Georgia. J Natl Cancer Inst 66:7-16, 1981.
21. Nomura AM, Stemmermann GN, Heilburn LK, Salkeld RM, Vuilleumier JP. Serum vitamin levels and the risk of cancer of specific sites in men of Japanese ancestry in Hawaii. Cancer Res 45:2369-2372, 1985.
22. Shekelle RB, Lepper M, Liu S, Maliza C, Raynor WJ Jr, Rossof AH, Paul O, Shryock AM, Stamler J. Dietary vitamin A and risk of cancer in the Western Electric study. Lancet 2:1185-1189, 1981.
23. Lotan R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochem Biophys Acta 605:33-91, 1980.
24. Lippman S, Kessler J, Meyskens FL Jr. Retinoids as preventive and therapeutic anticancer agents. Cancer Treat Rep 71:391-405,493-515, 1987.
25. Corbett MF, Herxheimer A, Magnus IA, Ramsay CA, Kobza-Black A. The long term treatment with β-carotene in erythropoietic protophyria: A controlled trial. Br J Dermatol 97:655-662, 1977.
26. Thomsen K, Schmidt H, Fischer A. β-Carotene in erythropoietic protophyria: 5-Years' experience. Dermatologica (Basel) 159:82-86, 1979.
27. Heywood R, Palmer AK, Gregson RL, Hummler H. The toxicity of β-carotene. Toxicology 36:91-100, 1985.
28. Kowalski TE, Falestiny M, Furth E, Malet PF. Vitamin A hepatotoxicity: A cautionary note regarding 25,000 IU supplements. Am J Med 97:523-528, 1994.
29. Geubel AP, de Galocsy C, Alves N, Rahier J, Dive J. Liver damage caused by therapeutic vitamin A administration: Estimate of dose-related toxicity in 41 cases. Gastroenterology 100:1701-1709, 1991.
30. Herbert V. Toxicity of 25,000 IU vitamin A supplements in "health" food users. Am J Clin Nutr 36:185-186, 1982.
31. Baker H, ten Hove W, Kanagasundaram N, Zaki G, Leevy CB, Frank O, Leevy CM. Case report: Excess vitamin A injures the liver. J Am College Nutr 9:503-509, 1990.
32. Babb RR, Kieraldo JH. Cirrhosis due to hypervitaminosis A. West J Med 128:244-246, 1978.
33. De Luca LM, Creek KE. Vitamin A and the liver. In: Popper H, Schaffner F, Eds. Progress in Liver Diseases. Orlando, FL: Grune & Stratton, Vol 8:pp81-9, 1986.
34. Goodman GE, Alberts DS, Earnst DL, Meyskens FL. Phase I trial of retinol in cancer patients. J Clin Oncol 1:394-399, 1983.
35. Goodman GE. Phase II trial of retinol in patients with advanced cancer. Cancer Treat Rep 70:1023-1024, 1986.
36. Meyskens FL Jr, Liu PY, Tuthill RJ, Sondak VK, Fletcher WS, Jewell WR, Samlowski W, Balcerzak SP, Rector DJ, Noyes D, Costanzi JJ. Randomized trial of vitamin A versus observation as adjuvant therapy in high-risk primary malignant melanoma: A Southwest Oncology Group study. J Clin Oncol 12:2060-2065, 1994.
37. Goodman GE, Omenn GS, Thornquist MD, Lund B, Metch B, Gylys-Colwell I. The Caroline and retinol efficacy trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers. Cancer Epidemiol Biomarkers Prev 2:389-396, 1993.
38. Omenn GS, Goodman GE, Thornquist MD, Rosenstock L, Barnhart S, Gylys-Colwell I, Metch B, Lund B. The carotene and retinol efficacy trial (CARET) to prevent lung cancer in high risk populations: Pilot study with asbestos-exposed workers. Cancer Epidemiol Biomarkers Prev 2:381-387, 1993.